SCHEMBL4381780

SCHEMBL4381780

CP(=O)(O)OOc1cccc2cccnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
LMNA P02545 4/20 0.48
METAP2 P50579 2/20 0.48
METAP1 P53582 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
RAB9A P51151 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 5/20 0.46
POLB P06746 1/20 0.46
HSP90AA1 P07900 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 1/20 0.44
USP2 O75604 1/20 0.44
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3011815 0.98 MAPT (0.48) MAPTLMNAMETAP2METAP1HDAC6
Butane SCHEMBL3022746 0.94 MAPT (0.48) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL3011820 0.85 MAPT (0.46) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL28128326 0.84 MAPT (0.51) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL721177 0.81 MAPT (0.48) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL4461219 0.78 SRC (0.57) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL4381777 0.78 LMNA (0.50) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL7261599 0.78 MAPT (0.54) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL24179773 0.75 LMNA (0.55) MAPTLMNAMETAP2METAP1HDAC6
SCHEMBL4381775 0.75 MAPT (0.58) MAPTLMNAMETAP2METAP1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629379-B2 Substituted phosphonate fluorescent sensors and use thereof QUEEN MARY & WESTFIELD COLLEGE (GB) 2009-12-08 US disclosed
US-20070049761-A1 Substituted phosphonate fluorescent sensors and use thereof QUEEN MARY & WESTFIELD COLLEGE (GB) 2007-03-01 US disclosed
EP-1625134-A2 SUBSTITUTED PHOSPHONATE FLUORESCENT SENSORS AND USE THEREOF QUEEN MARY & WESTFIELD COLLEGE (GB) 2006-02-15 EP disclosed
WO-2004101579-A2 SUBSTITUTED PHOSPHONATE FLUORESCENT SENSORS AND USE THEREOF QUEEN MARY & WESTFIELD COLLEGE (GB) 2004-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049761-A1 Substituted phosphonate fluorescent sensors and use thereof NR2E3, CASR, NR3C2 MAPT 4604/4885LMNA 1229/4885METAP2 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.